RVPH logo

RVPH

Reviva Pharmaceuticals Holdings Inc.

$0.45
-$0.01(-2.24%)
10
Overall
--
Value
10
Tech
--
Quality
Market Cap
$35.00M
Volume
1.23M
52W Range
$0.30 - $4.28
Target Price
$8.00
Order:

Income Statement

MetricTrendChart
2019
Feb
2020
Feb
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
OPERATING EXPENSES
Operating Expenses
$-152.8K$724.7K$2.4M$10.1M$28.2M$39.5M$30.8M
Research & Development
----$295.1K$4.9M$22.9M$31.4M$22.9M
Research Expense
----$295.1K$4.9M$22.9M$31.4M$22.9M
Selling, General & Administrative
----$2.1M$5.3M$5.4M$8.1M$7.9M
General & Administrative Expenses
----$2.1M$5.3M$5.4M$8.1M$7.9M
Salaries & Wages
----------$3.4M$1.6M
Depreciation & Amortization
----$591--------
Depreciation & Amortization
----$591--------
Other Operating Expenses
$152.8K$724.7K----$28.2M$-640.6K$-768.1K
OPERATING INCOME
Operating income
$-152.8K$-724.7K$-2.4M$-10.1M$-28.2M$-39.5M$-30.8M
EBITDA
$574.1K$-706.0K$-2.3M$-8.5M$-28.2M$-39.2M$-29.9M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
--$-1.3M$1.5M$2.4K----$18.5K
Intinc
$729.5K$1.9M$105.2K----$398.4K$361.4K
Net Non-Operating Interest Income/Expense
$729.5K$1.3M$-1.5M--$-182.8K$398.4K$361.4K
Gain on Sale of Securities
$-2.6K----$1.6M$-194.7K$-239.2K$717.6K
Other Income/Expense
$2.6K$-18.7K$-105.2K$-1.6M$-194.7K$104.9K$-556.7K
Other Special Charges
----$105.2K$-2.4K$-194.7K$134.3K$-160.9K
PRE-TAX INCOME
EBIT
$574.1K$-706.0K$-2.3M$-8.5M$-28.2M$-39.2M$-29.9M
Pre-Tax Income
$574.1K$617.9K$-3.8M$-8.5M$-28.2M$-39.2M$-29.9M
INCOME TAX
Tax Provision
----$800$6.0K$20.8K$16.9K$19.5K
NET INCOME
Net Income
$574.1K$617.9K$-3.8M$-8.5M$-28.3M$-39.3M$-29.9M
Net Income (Continuing Operations)
$574.1K$617.9K$-3.8M$-8.5M$-28.3M$-39.3M$-29.9M
Net Income (Discontinued Operations)
$574.1K$617.9K$-3.8M$-8.5M$-28.3M$-39.3M$-29.9M
Net Income (Common Stockholders)
$574.1K$617.9K$-3.8M$-8.5M$-28.3M$-39.3M$-29.9M
Normalized Income
------$-6.7M----$-29.6M
TOTALS
Total Expenses
$-152.8K$724.7K$2.4M$10.1M$28.2M$39.5M$30.8M
SHARE & EPS DATA
Average Shares Outstanding
$2.0M$2.6M$3.1M--$19.5M$23.8M$33.1M
Average Shares Outstanding (Diluted)
$14.4M$2.6M$3.1M--$19.5M$23.8M$33.1M
Shares Outstanding
$68.0M$7.7M$9.2M$68.0M$20.5M$27.9M$68.0M
Basic EPS
--$-0.21$-1.24--$-1.25$-1.65$-0.90
Basic EPS (Continuing Operations)
--$-0.21$-1.24--$-1.25$-1.65$-0.90
Diluted EPS
$-0.04$-0.21$-1.24--$-1.25$-1.65$-0.90
OTHER METRICS
Accretion On Preferred Stock
$-650.8K$1.2M----------
Minority Interests
--$5.0M----------
Net Operating Interest Income Expense
$729.5K------------
Other Gand A
----$2.1M$5.3M$5.4M$8.1M$7.9M
Otherunder Preferred Stock Dividend
$-650.8K$1.2M----------
Preferred Stock Dividends
$-650.8K$1.2M----------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2RVPH$0.45-2.2%1.23M
3
4
5
6

Get Reviva Pharmaceuticals Holdings Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.